The Lead Episode 75: A Discussion of Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation The aMAZE Randomized Clinical Trial-The Lead Episode 75 Speaker Information

The Lead Episode 75 Speaker Information

Pdf Summary

The document discusses the aMAZE randomized clinical trial on pulmonary vein isolation with or without left atrial appendage ligation in atrial fibrillation. The article is authored by various medical professionals including Dhanunjaya R. Lakkireddy, MD, and David J. Wilber, MD. The study was published in the Journal of the American Medical Association. The host of the discussion is Michael S. Lloyd, MD, from Emory University, with contributions from Michael Hoskins, MD, from New Mexico Heart Institute, and Lucas V. A. Boersma, MD, PhD, from St Antonius Hospital. <br /><br />The disclosures reveal that Michael Hoskins and Lucas V. A. Boersma have connections with companies like Boston Scientific, Adagio Medical, and Medtronic for honoraria, speaking, and consulting. Michael S. Lloyd has affiliations with Medtronic and Boston Scientific for honoraria, speaking, and consulting, as well as membership on advisory committees for Boston Scientific. No disclosures were reported by Michael S. Lloyd.<br /><br />The aMAZE trial compares the outcomes of pulmonary vein isolation with or without left atrial appendage ligation in atrial fibrillation patients. The discussion provides insights into the trial results and implications for the treatment of atrial fibrillation. Overall, the document presents a detailed overview of the trial, its authors, hosts, contributors, and relevant disclosures.

Keywords

aMAZE randomized clinical trial

pulmonary vein isolation

left atrial appendage ligation

atrial fibrillation

Dhanunjaya R. Lakkireddy

David J. Wilber

Journal of the American Medical Association

Michael S. Lloyd

Michael Hoskins

Lucas V. A. Boersma